United States: Court Grants Stay Of Entire Case Involving Eleven Patents While Patent Office Conducts Inter Partes Review Proceedings On Two Of The Patents


A Massachusetts court recently granted a motion to stay an infringement litigation involving 11 patents pending the outcome of inter partes review proceedings of 2 of the 11 asserted patents. Although the court acknowledged that a stay would not eliminate the need for a trial, the court found that a stay would simplify or streamline issues for trial because the case was still in its infancy; the 11 patents shared similar inventive disclosures; and the patent owner, a non-practicing entity, identified no specific prejudice that would result from a stay.

* * * * * * * * * *

Under the Leahy-Smith America Invents Act, inter partes review (IPR) provides an expedited procedure for challenging the validity of a patent before the U.S. Patent and Trademark Office (PTO) and its Patent Trial and Appeal Board (PTAB). To avoid unnecessary duplication, trial courts may consider staying a district court case, either in part or in full, until the PTAB reaches a decision on the validity of the challenged patent claims. Deciding a motion to stay while an IPR is pending is largely a case-specific inquiry. The court has discretion in determining whether granting a stay is appropriate and focuses on the following three factors: (1) the stage of the litigation; (2) whether a stay will simplify the issues in question and the trial of the case; and (3) whether a stay will unduly prejudice or present a clear tactical advantage to the nonmoving party. Recently, in ACQIS, LLC v. EMC Corp.,1 the U.S. District Court for the District of Massachusetts ordered that a case be stayed in its entirety until a decision issued in IPRs filed by the defendant on 2 of 11 patents-in-suit.


ACQIS, LLC sued EMC Corporation for infringement of 22 patent claims from 11 different patents, all directed to modular computer systems. ACQIS originally filed its case in the Eastern District of Texas, where the court consolidated it with three related infringement suits against other defendants. The court granted EMC's motion to transfer the action against EMC to the District of Massachusetts, delaying the effect of its ruling until after the court issued its claim construction ruling. In the interim, EMC filed IPR petitions challenging 3 of the 11 patents-in-suit. The PTO instituted IPRs of just 2 of the 3 patents, involving 3 of the 22 asserted patent claims. After the Texas court transferred the action to Massachusetts, EMC moved the court to stay the case in its entirety pending the outcome of the IPRs.

The ACQIS Decision

In evaluating the first factor, the stage of the litigation, the court noted that document and written discovery were currently underway but not yet complete. No depositions had been taken, expert discovery had not yet begun, and dispositive motions had not yet been prepared or filed. ACQIS argued that significant discovery had already occurred, referring specifically to nearly 1.5 million pages of documents already produced. But the court found that third parties had produced the majority of the documents and ACQIS would have incurred a large portion of the associated costs irrespective of the case against EMC, because of the overlap with the other cases filed by ACQIS. The court also focused on the fact that the original scheduling order had been vacated as a result of the transfer, and thus, at the time, there was no trial date, nor any set deadlines for discovery or dispositive motions. Ultimately, the court concluded that notwithstanding the fact that substantial discovery had taken place and a claim construction opinion had been issued, the parties and the court still faced a significant amount of work. In light of all of these considerations, the court found that the stage of the litigation weighed moderately in favor of a stay.

Regarding the second factor—whether a stay would lead to simplification of the issues and trial of the case—ACQIS argued that the outcome of the IPR proceedings would not eliminate the need for a trial or greatly simplify the issues, because only 2 of the 11 patents-in-suit and 3 of the 22 patent claims were under review in the IPRs. Although the court acknowledged that the IPRs most likely would not eliminate the need for a trial, it found that this factor still weighed slightly in favor of a stay. The court agreed with EMC that even though not all asserted patents and claims were involved in the IPRs the issues would still be streamlined due to the "significant overlap" between the 3 patent claims under IPR and the remaining 19 patent claims at issue in the litigation. In reaching its finding, the court noted that the patents-in-suit come from three patent families sharing similar inventive disclosures and the same key inventive aspect. Thus, the court found that the IPRs were likely to result in simplification of the issues regardless of their outcome and that denying a stay or only granting it in part could result in costly inefficiencies whereby portions of discovery or motion practice would have to be revisited after the IPRs.

The court also found that the third factor, whether a stay would unduly prejudice or present a clear tactical disadvantage to the nonmoving party, weighed in favor of a stay. The court first stated that ACQIS had not identified any actual prejudice that it would suffer if the entire case was stayed. One important consideration that the court focused on was that ACQIS is a non-practicing entity that does not sell products and, thus, is not directly competing with EMC. The court also found that even if the case were stayed, ACQIS would still have all of its legal and equitable remedies available and ACQIS identified no reason that monetary damages would be insufficient.

Finally, the court disagreed with ACQIS that EMC had unreasonably delayed in filing its IPR petitions or in moving for a stay. EMC filed its IPR petitions shortly after ACQIS served its infringement contentions, which identified the specific claims ACQIS asserted. The court found EMC's timing reasonable, in light of the vast number of claims in the asserted patents, fees for filing IPR petitions, and the PTAB's page limits for petitions. Moreover, EMC filed its motion to stay around one month after the PTO instituted the IPRs, which the court also found to be a reasonable amount of time. Thus, the court concluded EMC had acted reasonably and that a nine-month stay of the entire case until a decision issues in the IPRs was unlikely to cause undue prejudice or present a clear tactical disadvantage to ACQIS.

Having determined that all three factors weighed in favor of a stay, the court granted EMC's motion to stay the case in its entirety pending a decision in the IPRs.

Strategy and Conclusion

This case illustrates the far-reaching impact that the IPR challenges to patent validity can have on the pendency and resolution of patent litigations, holding that a stay of the entire litigation was appropriate even when only a portion of the asserted patents were challenged in the co-pending IPR proceedings.


1. The court's decision can be found at http://www.finnegan.com/files/upload/LES_Insights_Column/2015/Acquis_ v_EMCCorp.pdf.

Previously published in LES Insights

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Events from this Firm
22 Jan 2019, Webinar, Washington, DC, United States

As part of Strafford Publications’ webinar series, Finnegan partners Shana Cyr and Mark Feldstein will provide essential updates on FDA practice and patent law relating to biologics and biosimilars.

27 Jan 2019, Other, Washington, DC, United States

Finnegan is a sponsor of the Association of Corporate Patent Counsel Winter Meeting. Finnegan partner Erika Arner will join the panel discussion “PTAB Review & Litigation.”

27 Jan 2019, Other, Florida, United States

Finnegan is a sponsor of the Association of Corporate Patent Counsel Winter Meeting. Finnegan partner Erika Arner will join the panel discussion “PTAB Review & Litigation.

Similar Articles
Relevancy Powered by MondaqAI
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions